SCHEMBL9275

SCHEMBL9275

Nc1ncnc2c1ncn2CCCc1oc2ccccc2c(=O)c1-c1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.47
NSD3 Q9BZ95 1/20 0.47
ADORA2A P29274 6/20 0.45
LMNA P02545 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
EGFR P00533 3/20 0.41
ADCY5 O95622 3/20 0.40
ERBB2 P04626 1/20 0.40
BRAF P15056 1/20 0.40
KDR P35968 1/20 0.40
TEK Q02763 1/20 0.40
AURKB Q96GD4 1/20 0.40
PI4KA P42356 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40
PI4K2A Q9BTU6 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
MAPK14 Q16539 1/20 0.39
ADORA1 P30542 2/20 0.39
ADORA2B P29275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8117 0.95 ADORA2A (0.49) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL9569 0.94 ADORA2A (0.50) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL8993 0.91 NSD2 (0.44) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL9179 0.90 ADORA2A (0.47) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL30670890 0.89 ADORA2A (0.47) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL8166 0.89 ADORA2A (0.47) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL8479 0.89 ADORA2A (0.44) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL15688607 0.88 ADORA2A (0.55) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL8842 0.88 ADORA2A (0.47) NSD2NSD3ADORA2ALMNAHPGD
SCHEMBL8575 0.86 ADORA2A (0.46) NSD2NSD3ADORA2ALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 EP claimed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 WO claimed
EP-4292596-A1 METHOD AND COMBINATION FOR TREATING TUMORS Curon Biopharmaceutical (Shanghai) Co., Limited (CN) 2023-12-20 EP disclosed
EP-2916868-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR Rhizen Pharmaceuticals S.A. (CH) 2015-09-16 EP disclosed
WO-2014072937-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR RHIZEN PHARMACEUTICALS SA (CH) 2014-05-15 WO disclosed
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 EP disclosed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 WO disclosed